Skip to main content
Caplight Logo









Alchemi

Alchemi

Private
New York City, New YorkHealthcare & Life Scienceshttps://alchemi.bio

Last Round

Seed

Jul 22, 2024

Total Funding Raised

$3.3M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Alchemi operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in July 2024.

Alchemi is a life sciences and artificial intelligence company that develops an AI platform to accelerate drug development by automating regulated assay workflows.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Workflow Automation, Compliance & Risk

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Alchemi Comparables

Compare Alchemi with similar companies based on industry and business-model similarity.

Alchemi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Convoke
71%
Albert Invent
66%
Benchling
64%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Alchemi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 22, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Alchemi Investors

Notable investors and investment history

Alchemi investors
InvestorRounds
FlybridgeSeed
ForewordSeed
jtangoVCSeed
Olive CapitalSeed
Maple VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 26, 2026

    Open roles increased to 9, 41% of headcount.

  • Sep 16, 2026

    Grew 22% QoQ, from 18 to 22 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Alchemi Filings

Explore SEC and related filing metadata, where available.

Alchemi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Alchemi's valuation, stock price, and market status.

Is Alchemi a public or private company?

Alchemi is a private company.

What is the current stock price of Alchemi?

Alchemi is a private company, so its shares have no public market price. Caplight tracks Alchemi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Alchemi worth (valuation)?

Valuation information for Alchemi is not publicly available.

Can I buy Alchemi stock?

Alchemi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Alchemi's last funding round?

Alchemi's most recent funding round was Seed on July 22, 2024.

Who are the main investors in Alchemi?

Key investors in Alchemi include Flybridge, Foreword, jtangoVC, Olive Capital, Maple VC.

Will Alchemi IPO soon?

No public IPO plans have been announced for Alchemi.

How can I track Alchemi secondary market activity?

Caplight tracks bids, offers, and trades in Alchemi's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range15
Year Founded2024
Last FundingJul 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?